Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The GATOR2 complex (GAP activity towards Rags 2) is a highly conserved, pentameric multiprotein assembly consisting of five subunits: MIOS, WDR24, WDR59, SEH1L, and SEC13. It serves as a critical positive regulator of the mechanistic target of rapamycin complex 1 (mTORC1) signaling pathway by opposing the inhibitory activity of the GATOR1 complex in response to amino acid availability. Under nutrient-depleted conditions, GATOR2 is bound and inhibited by amino acid sensors such as Sestrin2 (for leucine) and CASTOR1 (for arginine). Upon amino acid sufficiency, these sensors dissociate, allowing GATOR2 to inhibit GATOR1, which subsequently promotes the lysosomal translocation and activation of mTORC1.
Beyond its role in mTORC1 activation, GATOR2 has been shown to regulate lysosomal-autophagic function and stabilize MiT/TFE transcription factors independently of mTORC1. Dysregulation of GATOR2 is implicated in various human pathologies, including cancer (such as PAX3-FOXO1-positive rhabdomyosarcoma, pancreatic ductal adenocarcinoma, and renal cell carcinoma), neurodegenerative diseases like Huntington's disease, and myelination defects. Consequently, GATOR2 represents an attractive therapeutic target, with small molecules like NV-5297 and NV-5138 designed to modulate its interaction with Sestrin2 to activate mTORC1, and other experimental inhibitors like Mi3 and Tanshinone IIA targeting its subunits to suppress tumor growth and induce autophagy.
Modulation of the Sestrin2-GATOR2 interaction to activate mTORC1, or direct inhibition of GATOR2 subunits (such as MIOS) to suppress mTORC1 activity and induce autophagy.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GATOR2 complex (GATOR2).